✦ LIBER ✦
6085 FOLFOXIRI (irinotecan, oxaliplatin, infusional 5FU/LV) vs FOLFIRI as first-line treatment of metastatic colorectal cancer (mCRC): updated results after 5 years follow up and risk-stratified analysis
✍ Scribed by Falcone, A.; Masi, G.; Vasile, E.; Loupakis, F.; Cupini, S.; Mancini, M.; Granetto, C.; Ribecco, A.; Andreuccetti, M.; Brunetti, I.M.
- Book ID
- 122923059
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 47 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.